BioXyTran, Inc. engages in the development, manufacture, and commercialization of therapeutic drugs designed to address hypoxia in humans, which is a lack of oxygen in tissues. Its product pipeline includes BXT-25, a drug designed to oxygenate ischemic (reduced blood flow) regions in the brain that suffered from hypoxia during a brain stroke, and BXT-252, which treats chronic wounds resulting from ischemia caused by occlusion of capillaries. The company was founded on June 9, 2008 and is headquartered in Needham, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3
Frequently Asked Questions
What is Market Cap of Bioxytran Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Bioxytran Inc market cap is $7.37M.
What is the 52-week high for Bioxytran Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Bioxytran Inc 52 week high is $0.2283 as of September 18, 2025.
What is the 52-week low for Bioxytran Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Bioxytran Inc 52 week low is $0.0606 as of September 18, 2025.
What is Bioxytran Inc stock price today?
Bioxytran Inc stock price today is $0.0769.
What was Bioxytran Inc stock price yesterday?
Bioxytran Inc stock price yesterday was $0.0828.
What is the PE ratio of Bioxytran Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Bioxytran Inc’s P/E ratio is -3.48.
What is the Price-to-Book ratio of Bioxytran Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Bioxytran Inc P/B ratio is -2.7495.
What is the 50-day moving average of Bioxytran Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Bioxytran Inc 50-day moving average is $0.0849.